Mechanistically, Senni et al. showed that CTNNB1, which encodes β-catenin in the Wnt pathway, can block the development of HCC by targeting the transcription factor Pparα, thereby blocking the metabolic reprogramming of fatty acid oxidation activated by β-catenin [45]. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.